Medications like Ozempic and Wegovy are famous for their weight loss benefits, but some scientists want to know more about ...

The demand for bariatric operations dropped sharply last year as use of anti-obesity drugs such as Wegovy surged, study finds ...

A systematic review of randomized controlled trials (RCTs) found that weight-loss interventions were associated with improvements in some polycystic ovary syndrome (PCOS) symptoms, including ...

It appears that patients experience some weight loss even after they stop taking the drug ... while still having plenty left over to invest in its other research and development (R&D) programs. It ...

Ozempic is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to help with blood sugar control ...

Axios Visuals Budget pressures have kept all but 13 states from covering GLP-1 drugs for weight loss through their Medicaid programs, a new report from KFF shows. Why it matters: The restrictive ...

The two major party candidates provide ample reasons for pessimism about the future of the republic. If you're a fanatical ...

Survey finds only 18% of respondents who discontinued GLP-1s achieved their weight loss goals; respondents want to lose an ...

The findings spell an uncertain future for hospitals and clinics that derive a significant portion of their revenues from ...

What: Young people with severe obesity who underwent weight-loss surgery at age 19 or younger continued to see sustained weight loss and resolution of common obesity-related comorbidities 10 years ...

Follow the latest news headlines from Australia's most trusted source. Read in-depth expert analysis and watch live coverage on ABC News.

Saturday on PBS News Weekend, Israel’s retaliatory attack on Iran fuels fears of a wider war in the Middle East. Then, for the third presidential election in a row, Michigan is playing a pivotal role.